Cross-clade simultaneous HIV drug resistance genotyping for reverse transcriptase, protease, and integrase inhibitor mutations by Illumina MiSeq

BACKGROUND: Viral resistance to antiretroviral therapy threatens our best methods to control and prevent HIV infection. Current drug resistance genotyping methods are costly, optimized for subtype B virus, and primarily detect resistance mutations to protease and reverse transcriptase inhibitors. Wi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Retrovirology
Main Authors: Dudley, Dawn M, Bailey, Adam L, Mehta, Shruti H, Hughes, Austin L, Kirk, Gregory D, Westergaard, Ryan P, O’Connor, David H
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4302432/
https://ncbi.nlm.nih.gov/pubmed/25533166
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12977-014-0122-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados